Poland is the largest medical device market in Central and Eastern Europe. Poland Medical Device Regulations run on two tracks at once. There’s the EU-wide Medical Device Regulation (EU) 2017/745 (MDR) and there’s the Polish Act of 7 April 2022 on Medical Devices which provides additional national rules. Manufacturers who treat the two as one and the same are usually the ones who get an unpleasant surprise from URPL.
URPL Medical Device Registration has its own notification timelines, its own fee structure and its own national registers that exist alongside EUDAMED. This article walks through the Poland Medical Device Registration Process from classification through post-market surveillance.
Regulatory Authorities for Medical Devices in Poland
One authority runs the show domestically, but the framework above it is European.
URPL: It is the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. The President of URPL implements Regulation (EU) 2017/745 and 2017/746 domestically, oversees notified bodies established in Poland, runs market surveillance, and manages the national device and economic-operator registers.
European Commission: Owns the MDR text itself and issues the Medical Device Coordination Group (MDCG) guidance documents that interpret it.
Polish Ministry of Health: They issue the implementing regulations that fill in operational detail like covering fees and incident-reporting templates.
EUDAMED: The EU’s central device database, meant to eventually replace a lot of national paperwork but hasn’t fully done so yet.
That gap between “EUDAMED should handle this” and “URPL currently handles this” is where most of the Poland-specific compliance work lies, and honestly, it confuses manufacturers more than the classification rules do.
Poland Medical Device Classification
Poland follows the EU classification system. There’s no separate Polish classification scheme running in parallel. Under MDR Annex VIII, devices fall into four risk-based classes based on rules covering duration of use and invasiveness.
Manufacturers classify their own device in the first instance. URPL steps in only where there’s a dispute or an ambiguous case, and it resolves those in line with MDR classification rules rather than inventing its own criteria.
| Class | Risk Level | Examples | Conformity Route |
| Class I | Low | Bandages, manual wheelchairs, examination gloves |
Self-declaration (Notified Body only for sterile, measuring, or reusable-surgical features)
|
| Class IIa | Low–medium | Hearing aids, dental fillings, ultrasound equipment | Notified Body assessment |
| Class IIb | Medium–high | Infusion pumps, ventilators, orthopedic implants | Notified Body assessment |
| Class III | Highest | Heart valves, coronary stents, implantable pacemakers | Notified Body assessment |
Authorized Representative (EC REP) Requirements in Poland
Article 11 of the MDR requires non-EU manufacturers to appoint an Authorized Representative established within the Union before the device is placed on the EU market. This applies whether the first target country is Poland or anywhere else in the bloc. The EC REP doesn’t have to be Polish, just EU-based.
The EC REP’s responsibilities include:
- Keeping the technical documentation and Declaration of Conformity available on file
- Acting as the contact point for URPL and other national authorities
- Cooperating on corrective actions and safety issues
- Forwarding serious incident reports
- Having their name and address appear on the device label or packaging
Medical Device Regulatory Guidelines in Poland
Poland MDR Compliance runs across three layers:
- MDR (EU 2017/745) sets EU-wide requirements for performance, and market access.
- Polish Act of 7 April 2022 on Medical Devices supplements the MDR with national obligations such as registration of economic operators, advertising rules and an administrative penalty regime.
- Ministry of Health implementing regulations including the Regulation of 26 July 2022 on fees for medical devices and a separate Ministry of Health regulation on the advertising of medical devices.
The Act entered into force on 26 May 2022, with the registration-related provisions for distributors, professional users, manufacturers and importers of custom-made devices phased in through 1 July 2023, and a transition period for switching to the new online registers that has since run its course.
MDCG guidance documents fill in interpretive gaps the Act and MDR leave open, particularly on classification borderlines and clinical evaluation expectations.
Medical Device Registration Process in Poland
Get this sequence right and CE marking plus URPL notification move in parallel instead of colliding. Here’s the order that works.
Step 1: Confirm that the device is in scope and classify it.
Everything downstream depends on getting this right under MDR Annex VIII. Verify against the classification rules directly.
Step 2: Set up your Quality Management System.
ISO 13485 is the practical baseline here, and it needs to be in place before technical documentation is finalized.
Step 3: Appoint an EU Authorized Representative
A non-EU manufacturer must appoint an EU REP. This step gates almost everything else. Without it, manufacturers can’t proceed to registration or CE marking.
Step 4: Complete conformity assessment and Medical Device CE Marking Poland manufacturers need for market access
Class I devices (excluding sterile, measuring and reusable-surgical variants) can self-declare. Everything else needs notified body involvement per MDR Annex IX, X or XI.
Step 5: Register in EUDAMED and obtain a Single Registration Number (SRN)
This runs under Article 31 of the MDR together with the Polish Act’s registration provisions.
Step 6: Notify URPL.
Under the transitional national notification rules, the manufacturer or Polish-based Authorized Representative must notify the President of URPL at least 14 days before placing the first product on the market or submitting it for performance evaluation. Importers bringing a device into Poland for the first time have a separate 7-day notification window from the date the product enters Polish territory.
Step 7: Register as a distributor or importer, where applicable.
Distributors making a device available in Poland for the first time must request access credentials from URPL and enter Basic UDI-DI and manufacturer data into the national distributor list within 7 days of first supply.
Step 8: Apply Polish-language labelling and place the device on the market
Devices found on shelf with incomplete Polish labelling are one of the more common triggers for a market surveillance query.
Step 9: Maintain post-market surveillance and vigilance reporting
This runs for the life of the device, not just the first year after launch.
Required Documents for Medical Device Registration in Poland
The exact list changes with device class, but a core set of documents shows up in every submission.
- Declaration of Conformity
- Technical documentation covering device description and intended use
- Risk management documentation aligned with ISO 14971
- Polish translations of labelling, instructions for use, and the declaration itself, where these are submitted to URPL
For Class IIa and above, add clinical evaluation documentation and evidence of notified body certification. For custom-made devices, the manufacturer, EC REP or importer must additionally register their activity with URPL before the device is placed on the market. This requirement came into force on 1 July 2023.
QMS Requirements for Medical Devices in Poland
There’s no Polish-specific Quality Management System(QMS) standard sitting apart from the European one. ISO 13485 is what URPL and notified bodies expect to see and it’s the practical requirement for demonstrating MDR compliance in:
- Design control
- Production and process control
- Supplier management
- Complaint handling and CAPA
- Post-market surveillance
Risk management is addressed alongside it under ISO 14971, which the MDR references directly for the risk analysis manufacturers must run through the device lifecycle. An ISO 13485 certificate is typically valid for three years, with annual surveillance audits in between.
Medical Device Labelling Requirements in Poland
Labelling and instructions for use for devices distributed in Poland must be provided in Polish. There’s a narrow exception:
- Harmonised symbols can substitute for some label content.
- Where a device is supplied to a specific healthcare facility with that facility’s written consent, labelling and IFU can be in English except for anything intended for the patient directly, which still needs to be in Polish or expressed through recognised symbols.
- If the primary packaging is labelled in Polish, the unit packaging generally follows suit in Polish too or uses harmonised symbols consistently.
Beyond language, the substantive labelling content like UDI, manufacturer details, EC REP details for non-EU manufacturers, batch or serial number, intended purpose and warnings follows MDR Annex I general labelling requirements.
Registration Timelines for Medical Devices in Poland
Poland Medical Device Registration Timeline depends on the pathway.
| Activity | Typical Timeline |
| URPL notification (manufacturer/EC REP, pre-market | Minimum 14 days before market placement |
| Importer notification to URPL | Within 7 days of first product entering Poland |
| Distributor first-supply registration | Within 7 days of first supply in Poland |
| Class I self-declared conformity | Weeks, once technical file is ready |
| Class IIa/IIb/III notified body review |
Runs on notified body capacity and queue. Commonly several months and up to a year or more for complex Class III files
|
The MDR itself doesn’t set a fixed statutory review period for notified body assessment. The timeline is a function of the notified body’s own workload and the completeness of the submission and it’s worth confirming directly with your chosen notified body rather than assuming a figure.
Medical Device Registration Costs in Poland
Fees for URPL-related medical device activities are set under the Regulation of the Minister of Health of 26 July 2022 on fees for medical devices. The specific fee schedule varies by activity type like notification, classification consultation, custom-made device registration and by device class.
Fee schedules under Ministry of Health regulations do get revised periodically. The exact current figures are published in full at ISAP under the Regulation of the Minister of Health of 26 July 2022 on fees for medical devices.
Import Requirements for Medical Devices in Poland
Getting CE marking done isn’t the finish line for import. Non-EU manufacturers still need an EU importer of record, and under the Polish Act, the importer must obtain authorization from the President of URPL to operate as an importer.
Practically, that means:
- The importer notifies URPL within 7 days of the first product entering Polish territory.
- The notification must be accompanied by Polish translations of the declaration of conformity, labelling, and instructions for use.
- The importer is responsible for confirming the manufacturer has assigned a UDI to the device before it’s placed on the Polish market.
Post-Market Surveillance (PMS) Requirements in Poland
PMS obligations under the MDR apply in Poland exactly as they do across the EU. There’s no separate Polish PMS standard, just the national reporting channel through URPL. Manufacturers must run a post-market surveillance system proportionate to device risk, covering:
- Complaint handling
- Trend analysis
- Periodic safety reporting where applicable under MDR post-market surveillance and vigilance chapter
Serious incidents and Field Safety Corrective Actions get reported to URPL using the template set out in the Ministry of Health’s Regulation on serious incident reporting. URPL runs its materiovigilance function to monitor and analyse these reports and can order corrective action, market withdrawal or the destruction of non-compliant products where warranted.
Conclusion
Medical Device Registration in Poland rewards manufacturers who treat the Polish layer as a real compliance workstream. Classification under MDR Annex VIII, an EC REP appointed early, URPL notification built into the launch timeline, Polish-language labelling done properly the first time, and a PMS system that’s actually operational from day one, all these combinations is what keeps market entry on schedule.
If you need support with medical device registration, technical documentation, EU MDR compliance, URPL notification requirements or regulatory strategy for the Polish market, reach out to the experts at info@artixio.com for guidance tailored to your market entry goals.
FAQs
Q1. Is CE marking enough to sell a medical device in Poland?
No. CE marking demonstrates MDR compliance at EU level, but Poland Medical Device Regulatory Requirements still call for URPL notification, Polish-language labelling and importer or distributor registration in the national registers before the device can be legally marketed in Poland.
Q2. Who needs to register with URPL, and when?
Manufacturers or their Polish-based Authorized Representative must notify URPL at least 14 days before market placement. Importers have a separate 7-day window from first entry of the product into Poland and distributors making a device available for the first time must register within 7 days as well.
Q3. Does Poland Medical Device Classification differ from the rest of the EU?
No. Poland applies the same four-class MDR Annex VIII system used across the EU. There’s no separate Polish classification scheme, though URPL can be asked to resolve classification disputes.
Q4. What happens if a serious incident occurs after the device is on the Polish market?
It gets reported to URPL using the Ministry of Health’s prescribed template, feeding into URPL’s materiovigilance monitoring. Depending on severity, URPL can require corrective action or order product withdrawal.
Q5. Where can Medical Device Classification Poland disputes be resolved if a manufacturer disagrees with a notified body?
Classification disagreements go through URPL, which resolves them against the MDR Annex VIII rules rather than a separate national standard. Persistent ambiguity can also be referred through MDCG channels at EU level.
